Zambia has formally signed a five year health cooperation agreement with the United States, bringing an end to months of disagreement over provisions concerning medical information, biological specimens and the country’s critical mineral resources.
The agreement, signed in Lusaka on Thursday, October 8, 2026, establishes a new framework under which Washington will provide more than $1.5 billion towards Zambia’s priority health programmes, while the Zambian government has committed to increasing domestic health expenditure by $975 million over the same five year period. The United States Government places the combined value of the partnership at approximately $2.49 billion.
The signing follows prolonged negotiations after an earlier version of the proposed agreement generated considerable controversy in Zambia. Civil society organisations, health advocates and other campaigners had expressed concern that the original provisions could give the United States extensive access to sensitive health information and biological material collected from Zambian citizens.
Those concerns were subsequently addressed during negotiations, with the Zambian authorities securing the removal of provisions requiring the transfer of biological specimens and individual patient information to the United States. Under the revised arrangement, information exchanged between the two countries will be restricted to data directly connected to the implementation, monitoring and evaluation of programmes financed under the partnership.
Zambia’s Health Minister, Professor Roma Chilengi, said the revised agreement contains no requirement for the country to surrender biological specimens to Washington and does not permit the transfer of personally identifiable patient records. He said the revised framework would instead allow Zambia to strengthen its health information systems while retaining control over sensitive national health information.
The agreement is expected to finance a broad range of programmes, including HIV and AIDS treatment, tuberculosis and malaria control, maternal and child healthcare, disease surveillance, outbreak preparedness and the wider strengthening of Zambia’s health system. It will also support the recruitment of as many as 40,000 health workers during the five year period, according to Zambian officials.
The new arrangement represents a significant departure from the traditional donor recipient structure that previously characterised much of American health assistance to Zambia. Washington is seeking a model in which recipient governments progressively assume greater responsibility for financing and managing their own health systems, while American support is directed towards strengthening institutional capacity and responding to major health threats.
The United States has described the approach as part of President Donald Trump’s America First Global Health Strategy, which places greater emphasis on national ownership, shared financial responsibility and the eventual self reliance of partner countries. The State Department said the new framework is intended to strengthen Zambia’s ability to procure essential medicines, integrate health workers into its public service and improve systems for detecting and responding to infectious disease threats.
The agreement also resolves a separate diplomatic dispute over whether American health financing was connected to Zambia’s substantial deposits of copper and other critical minerals.
Earlier negotiations had generated accusations from Zambian officials and activists that Washington was attempting to connect health assistance with preferential access to the country’s mineral resources. Foreign Affairs Minister Mulambo Haimbe had previously raised concerns about the two issues being treated as part of a broader package.
The Zambian government now says the health agreement and discussions concerning critical minerals have been formally separated. Minister Haimbe said the two matters would be handled independently, removing the mineral question from the health financing arrangement.
The dispute over the agreement emerged against the backdrop of a major restructuring of American foreign assistance under the Trump administration. Following President Trump’s return to office in January 2025, Washington moved to dismantle the United States Agency for International Development, or USAID, amid accusations that the agency had operated inefficiently and spent American resources wastefully.
The restructuring disrupted health programmes across several African countries that had relied heavily on American financial and logistical assistance. The Trump administration subsequently began pursuing direct bilateral health arrangements with individual African governments rather than relying primarily on the previous donor and international organisation model.
That approach has generated mixed reactions across the continent. Some governments have accepted the new framework, while others have resisted provisions involving health information, biological specimens and the potential commercial use of data generated within their health systems.
Ghana and Zimbabwe have been among the countries that raised objections to proposed arrangements, particularly over the scope of data sharing and questions surrounding control of medical information. Kenya also faced legal challenges over its agreement after concerns were raised about the protection of patient privacy.
The controversy reflects wider concerns about the ownership and value of African health information. During the COVID 19 pandemic, African countries witnessed the importance of pathogen information and genetic research in developing vaccines and treatments, while also experiencing difficulties obtaining sufficient supplies of medicines and vaccines once those products became available.
Health advocates have therefore argued that African countries should not simply provide valuable medical information and biological resources without securing meaningful protections, ownership rights and equitable access to treatments or technologies developed from such material.
The United States, however, maintains that responsible information exchange is essential for scientific cooperation and the early detection of infectious diseases. American officials have argued that aggregated and deidentified information can assist both countries in strengthening disease surveillance and responding more rapidly to emerging health threats.
Zambia’s revised agreement is consequently being presented by its government as an attempt to preserve the benefits of American health financing while removing provisions that officials and civil society groups considered unacceptable.
The agreement comes at a time when Zambia is confronting significant financial pressures and preparing for possible economic difficulties associated with global conditions and the threat of severe drought. Finance Minister Situmbeko Musokotwane said continued American assistance would provide additional fiscal space for the government to direct resources towards other national priorities.
For Washington, the agreement is also intended to strengthen regional health security. American officials argue that infectious diseases do not respect national boundaries and that a stronger Zambian health system will improve the ability of both countries and the wider region to detect and contain emerging outbreaks.
The signing therefore marks more than the conclusion of a disputed funding arrangement. It signals Zambia’s decision to continue its longstanding health partnership with the United States while negotiating stricter boundaries around medical information, biological resources and national economic interests.
The final agreement also illustrates the increasingly complex relationship between American foreign assistance and strategic interests in Africa, as Washington seeks to reduce its traditional donor role while encouraging African governments to assume a greater share of responsibility for financing and managing their own healthcare systems.
